GlassScriptPhysician profile
Daniel R Conway
NPI 1477518462
$2,424.92
in general payments reported to CMS, 2019-2025
30 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $122 · 2021: $193 · 2022: $140 · 2023: $587 · 2024: $345 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $433.08 | 2019-2022 | |
| Ethicon US, LLC | $288.35 | 2023-2024 | Echelon Flex, Echelon Circular, Echelon; Endopath |
| Davol INC. | $149.78 | 2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $131.08 | 2019 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.96 | 2022-2024 | Gattex |
| Csl Behring | $116.20 | 2019-2024 | Kcentra |
| Boston Scientific Corporation | $109.00 | 2021-2024 | Rezum Generator |
| Genentech USA, INC. | $99.00 | 2019 | |
| Kerecis Limited | $95.62 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Conmed Corporation | $90.86 | 2019-2024 | Airseal |
| Merck Sharp & Dohme LLC | $75.49 | 2023-2025 | Keytruda, Lynparza |
| Apollo Endosurgery US INC | $68.42 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $68.02 | 2024-2025 | |
| Trevena, INC. | $62.78 | 2023 | Olinvyk |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $52.29 | 2025 | Gemtesa |
| Dilon Technologies, INC. | $46.67 | 2023 | Hemoblast Bellows |
| Olympus America INC. | $41.82 | 2019-2023 | Itind System, Soltive |
| Becton, Dickinson and Company | $38.94 | 2025 | Bard Urinary Drainage Bag, Magic3 Intermittent Catheter |
| Procept Biorobotics Corporation | $30.86 | 2021-2022 | |
| Tei Biosciences INC | $27.52 | 2019 | |
| Neotract INC. | $24.91 | 2019-2020 | |
| Medtronic, INC. | $24.29 | 2025 | Dextile |
| Myriad Genetic Laboratories, INC. | $17.36 | 2024 | Prolaris |
| Smith+Nephew, INC. | $17.21 | 2024 | Oasis, Stravix Pl |
| Monaghan Medical Corporation | $17.05 | 2023 | Aerochamber |
| Lemaitre Vascular, INC. | $14.03 | 2024 | Artegraft Vascular Graft |
| Tolmar Pharmaceuticals, INC. | $13.56 | 2021 | |
| Abbott Laboratories | $12.42 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.